Xin Lang Cai Jing·2026-02-26 06:43Group 1 - The core viewpoint of the news is that WuXi AppTec's stock has experienced fluctuations, with a recent decline of 2.00% and a year-to-date increase of 7.95% [1][2] - As of February 26, the stock price is reported at 97.85 CNY per share, with a total market capitalization of 291.96 billion CNY [1] - The company has seen a net outflow of 206 million CNY in principal funds, with significant selling pressure compared to buying [1] Group 2 - WuXi AppTec's main business involves a comprehensive platform service for the discovery, development, and production of small molecule chemical drugs, with revenue composition being 78.37% from chemical business, 12.93% from testing, and 6.02% from biological business [2] - The company reported a revenue of 32.857 billion CNY for the first nine months of 2025, reflecting a year-on-year growth of 18.61%, and a net profit of 12.076 billion CNY, up 84.84% [2] - The company has distributed a total of 14.06 billion CNY in dividends since its A-share listing, with 10.406 billion CNY in the last three years [3]